DIN 02031094 — LAMISIL 1 %
LAMISIL is a cream of Terbinafine marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Terbinafine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02031094
- Brand name
- LAMISIL
- Active ingredient
- Terbinafine
- Strength
- 1 %
- Dosage form
- CREAM
- Route
- TOPICAL
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Allylamine antifungal agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Terbinafine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02239893 | APO-TERBINAFINE | 250 MG | TABLET | APOTEX INC | MARKETED |
| 02320134 | AURO-TERBINAFINE | 250 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02238703 | LAMISIL | 1 % | SPRAY | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 02294273 | PMS-TERBINAFINE | 250 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02353121 | TERBINAFINE | 250 MG | TABLET | SANIS HEALTH INC | DORMANT |
| 02385279 | TERBINAFINE | 250 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED |
| 02242735 | TERBINAFINE-250 | 250 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02254727 | TEVA-TERBINAFINE | 250 MG | TABLET | TEVA CANADA LIMITED | MARKETED |